Your browser doesn't support javascript.
loading
Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke.
Demeestere, Jelle; Qureshi, Muhammad M; Vandewalle, Lieselotte; Wouters, Anke; Strbian, Daniel; Nogueira, Raul G; Nagel, Simon; Yamagami, Hiroshi; Puetz, Volker; Abdalkader, Mohamad; Haussen, Diogo C; Mohammaden, Mahmoud H; Möhlenbruch, Markus A; Olivé-Gadea, Marta; Winzer, Simon; Ribo, Marc; Michel, Patrik; Marto, João Pedro; Tanaka, Kanta; Yoshimura, Shinichi; Martinez-Majander, Nicolas; Caparros, Francois; Henon, Hilde; Tomppo, Liisa; Dusart, Anne; Bellante, Flavio; Ramos, João Nuno; Jesser, Jessica; Sheth, Sunil A; Ortega-Gutiérrez, Santiago; Siegler, James E; Nannoni, Stefania; Kaesmacher, Johannes; Dobrocky, Tomas; Salazar-Marioni, Sergio; Farooqui, Mudassir; Virtanen, Pekka; Ventura, Rita; Zaidi, Syed F; Castonguay, Alicia C; Uchida, Kazutaka; Puri, Ajit S; Sakai, Nobuyuki; Toyoda, Kazunori; Farzin, Behzad; Masoud, Hesham E; Klein, Piers; Bui, Jenny; Rizzo, Federica; Kaiser, Daniel P O.
Afiliação
  • Demeestere J; Laboratory for Neurobiology, KU Leuven, Belgium (J.D., L.V., A.W., R.L.).
  • Qureshi MM; Neurology, UZ Leuven, Belgium (J.D., L.V., A.W., R.L.).
  • Vandewalle L; Radiology (M.M.Q., M.A., P.K., J.B., T.N.N.), Boston Medical Center, MA.
  • Wouters A; Radiation Oncology (M.M.Q.), Boston Medical Center, MA.
  • Strbian D; Boston University Chobanian & Avedisian School of Medicine, MA (M.M.Q., M.A., P.K., T.N.N.).
  • Nogueira RG; Laboratory for Neurobiology, KU Leuven, Belgium (J.D., L.V., A.W., R.L.).
  • Nagel S; Neurology, UZ Leuven, Belgium (J.D., L.V., A.W., R.L.).
  • Yamagami H; Laboratory for Neurobiology, KU Leuven, Belgium (J.D., L.V., A.W., R.L.).
  • Puetz V; Neurology, UZ Leuven, Belgium (J.D., L.V., A.W., R.L.).
  • Abdalkader M; Neurology (D.S., N.M.-M., L.T.), Helsinki University Hospital, Finland.
  • Haussen DC; University of Helsinki, Finland (D.S., N.M.-M., L.T., P.V.).
  • Mohammaden MH; Neurology, Neurosurgery, University of Pittsburgh Medical Center, MA (R.G.N.).
  • Möhlenbruch MA; Neurology, Grady Memorial Hospital, Atlanta, GA (R.G.N., D.C.H., M.H.M.).
  • Olivé-Gadea M; Neurology, Klinikum Ludwigshafen, Germany (S.N.).
  • Winzer S; Neurology (S.N., P.A.R.), Heidelberg University Hospital, Germany.
  • Ribo M; Stroke Neurology, NHO Osaka National Hospital, Japan (H.Y.).
  • Michel P; Neurology (V.P., S.W.), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Marto JP; Dresden Neurovascular Center (V.P., S.W., D.P.O.K.), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Tanaka K; Radiology (M.M.Q., M.A., P.K., J.B., T.N.N.), Boston Medical Center, MA.
  • Yoshimura S; Boston University Chobanian & Avedisian School of Medicine, MA (M.M.Q., M.A., P.K., T.N.N.).
  • Martinez-Majander N; Neurology, Grady Memorial Hospital, Atlanta, GA (R.G.N., D.C.H., M.H.M.).
  • Caparros F; Neurology, Grady Memorial Hospital, Atlanta, GA (R.G.N., D.C.H., M.H.M.).
  • Henon H; Neuroradiology (M.A.M., J.J.), Heidelberg University Hospital, Germany.
  • Tomppo L; Neurology, Hospital Vall d'Hebron, Barcelona, Spain (M.O.G., M.R., F.R.).
  • Dusart A; Neurology (V.P., S.W.), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Bellante F; Dresden Neurovascular Center (V.P., S.W., D.P.O.K.), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Ramos JN; Neurology, Hospital Vall d'Hebron, Barcelona, Spain (M.O.G., M.R., F.R.).
  • Jesser J; Neurology, Lausanne University Hospital and University of Lausanne, Switzerland (P.M., D.S.).
  • Sheth SA; Neurology (J.P.M., R.V.), Hospital de Egas Moniz, Centro Hospitalar Lisboa Occidental, Lisbon, Portugal.
  • Ortega-Gutiérrez S; Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan (K. Tanaka, K. Toyoda).
  • Siegler JE; Neurosurgery, Hyogo Medical University, Nishinomiya, Japan (S.Y., K.U.).
  • Nannoni S; Neurology (D.S., N.M.-M., L.T.), Helsinki University Hospital, Finland.
  • Kaesmacher J; University of Helsinki, Finland (D.S., N.M.-M., L.T., P.V.).
  • Dobrocky T; Neurology, Centre Hospitalier Universitaire de Lille, France (F.C., H.H., C.C.).
  • Salazar-Marioni S; Neurology, University of Lille, France (F.C., H.H., C.C.).
  • Farooqui M; Neurology, Centre Hospitalier Universitaire de Lille, France (F.C., H.H., C.C.).
  • Virtanen P; Neurology, University of Lille, France (F.C., H.H., C.C.).
  • Ventura R; Neurology (D.S., N.M.-M., L.T.), Helsinki University Hospital, Finland.
  • Zaidi SF; University of Helsinki, Finland (D.S., N.M.-M., L.T., P.V.).
  • Castonguay AC; Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium (A.D., F.B.).
  • Uchida K; Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium (A.D., F.B.).
  • Puri AS; Radiology (J.N.R.), Hospital de Egas Moniz, Centro Hospitalar Lisboa Occidental, Lisbon, Portugal.
  • Sakai N; Neuroradiology (M.A.M., J.J.), Heidelberg University Hospital, Germany.
  • Toyoda K; Neurology, UTHealth McGovern Medical School, Houston, TX (S.A.S., S.S.-M.).
  • Farzin B; Neurology, University of Iowa, Iowa City (S.O.G., M.F.).
  • Masoud HE; Neurology, University of Chicago, IL (J.E.S.).
  • Klein P; Clinical Neurosciences, University of Cambridge, United Kingdom (S.N.).
  • Bui J; Diagnostic and Interventional Neuroradiology, University Hospital Bern, Switzerland (J.K., T.D.).
  • Rizzo F; Diagnostic and Interventional Neuroradiology, University Hospital Bern, Switzerland (J.K., T.D.).
  • Kaiser DPO; Neurology, UTHealth McGovern Medical School, Houston, TX (S.A.S., S.S.-M.).
Stroke ; 55(7): 1767-1775, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38748598
ABSTRACT

BACKGROUND:

Studies comparing bridging intravenous thrombolysis (IVT) with direct endovascular therapy (EVT) in patients with acute ischemic stroke who present late are limited. We aimed to compare the clinical outcomes and safety of bridging IVT in patients with acute ischemic stroke due to anterior circulation large vessel occlusion who underwent EVT 6 to 24 hours after time last known well.

METHODS:

We enrolled patients with anterior circulation large vessel occlusion stroke and a National Institutes of Health Stroke Scale score of ≥6 from 20 centers across 10 countries in the multicenter retrospective CLEAR study (CT for Late Endovascular Reperfusion) between January 2014 and May 2022. We used inverse probability of treatment weighting modeling adjusted for clinical and imaging confounders to compare functional outcomes, reperfusion success, symptomatic intracranial hemorrhage, and mortality between EVT patients with and without prior IVT.

RESULTS:

Of 5098 patients screened for eligibility, we included 2749 patients, of whom 549 received bridging IVT before EVT. The timing of IVT was not recorded. Witnessed stroke onset and transfer rates were higher in the bridging IVT group (25% versus 12% and 77% versus 55%, respectively, P value for both <0.0001), and time intervals between stroke onset and treatment were shorter (time last known well-start of EVT median 560 minutes [interquartile range, 432-791] versus 724 minutes [interquartile range, 544-912]; P<0.0001). After adjustment for confounders, there was no difference in functional outcome at 3 months (adjusted common odds ratio for modified Rankin Scale shift, 1.03 [95% CI, 0.89-1.19]; P=0.72) or successful reperfusion (adjusted odds ratio, 1.19 [95% CI, 0.81-1.75]; P=0.39). There were no safety concerns associated with bridging IVT versus direct EVT (symptomatic intracranial hemorrhage adjusted odds ratio, 0.75 [95% CI, 0.38-1.48]; P=0.40; mortality adjusted odds ratio, 1.14 [95% CI, 0.89-1.46]; P=0.31). Results were unchanged when the analysis was limited to patients who received IVT >6 hours after last known well.

CONCLUSIONS:

In patients with an anterior circulation large vessel occlusion stroke who underwent EVT 6 to 24 hours from last known well, bridging IVT was not associated with a difference in outcomes compared with direct EVT. REGISTRATION URL https//www.clinicaltrials.gov; Unique identifier NCT04096248.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Trombolítica / Procedimentos Endovasculares / AVC Isquêmico Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Trombolítica / Procedimentos Endovasculares / AVC Isquêmico Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Ano de publicação: 2024 Tipo de documento: Article
...